News

Cataract surgery with the Akreos MI60 microincision lens (Bausch & Lomb) is a safe and effective procedure.

Excellent visual outcomes can be achieved in subjects with mixed astigmatism when using the VISX wavefront platform's CustomVue iris registration system (AMO).

The implantation of multifocal and accommodative intraocular lenses (IOLs) can offer adequate near and far vision in addition to high levels of patient satisfaction.

Patients implanted with a hydrophilic intraocular lens (IOL) develop more posterior capsule opacification (PCO) and have worse visual acuity (VA), contrast sensitivity and glare after two years, compared with patients implanted with a hydrophobic IOL.

Descemetorhexis with endokeratoplasty (DXEK) has a direct effect on corneal hysteresis and the biomechanical properties of the human cornea.

Following enhancement with IntraLase bioptics, nearly all patients with high preoperative astigmatism can achieve spectacle independence.

Corneal collagen cross-linking with riboflavin, without removing the epithelium, is both safe and effective.

Non-penetrating filtering surgery with intraoperative mitomycin C (MMC) and without a scleral implant, can provide reasonable intraocular pressure (IOP) control.

Iris retractors are a safe and useful addition to small pupil phacoemulsification.

Implanting the Toric Implantable Collamer Lens (TICL; STAAR Surgical) to correct various degrees of myopia and compound myopic astigmatism, produces predictable refractive results.

In the treatment of myopia, STAAR Surgical's Visian ICL (Implantable Collamer Lens) is a preferable alternative to corneal refractive surgery, according to a panel of experts speaking at the STAAR Surgical symposium.

Epithelial thickness profiles may make it possible for LASIK to be performed in eyes that may otherwise have been excluded because of topographic suspect keratoconus.

The use of temporary pupil rings for pupil dilation during microincision cataract surgery (MICS) is particularly useful in cases with floppy iris syndrome.

Central corneal thickness (CCT) measurements should be carries out on all glaucoma patients in order to help set an accurate target intraocular pressure (IOP) range.

Combined phacoemulsification and viscocanalostomy achieves excellent intraocular pressure (IOP) control and improves visual acuity (VA) in patients with co-existing cataract and pseudoexfoliation glaucoma (PEXG).

Schwind eye-tech-solution's latest unveiling, the SCHWIND AMARIS excimer laser, provides excellent visual acuity (VA) results, high predictability and low variance in results.

Long-term follow-up has demonstrated that LASIK is a safe procedure even in high risk, highly myopic eyes.

OccuLogix today announced the completion of enrolment for the SOLX 790 titanium laser trabeculoplasty (TLT) clinical trial, which the firm hopes will support its application for 510(k) clearance with the FDA.

WaveLight today raised the curtain on its fine-tuned, new generation microkeratome, RONDO.

Excellent visual results can be obtained with microincision prelex in selected patients bilaterally implanted with the Acri.Lisa lens (Acri.Tec) through a 1.5 mm incision and combined with astigmatic surgery when needed.

Topical bevacizumab (Avastin) has shown excellent preliminary results and good topical tolerance when used in the prevention of corneal transplant failure.

Postoperative refraction following photorefractive keratectomy (PRK) remains stable from the second year postoperatively through to eight years.

Residual astigmatism plays an important role in the quality of visual outcome after cataract surgery, so astigmatism correction must be targeted during cataract surgery. This is especially relevant in cases over 3 D of corneal astigmatism.

Continuing on the path of IOL innovation, *Acri.Tec today unveiled the latest offering from its family of lenses in the form of the monotoric bifocal Acri.LISA Toric 466 TD lens.

Gene defect technology can be used to prevent corneal allograft rejection and the decay of endothelial cells in ex vivo corneal transplantation.

Three years of research and development paid off today when Schwind eye-tech-solutions unveiled the Schwind AMARIS excimer laser to the refractive surgery community. According to CEO Rolf Schwind, it successfully combines all available state-of-the-art technologies in one single system.

It is possible to select aspheric intraocular lenses (IOLs) based on preoperative corneal spherical aberration (SA).

An omni-focal approach, combining an aspheric prebyopic treatment with a hyperopic ablation, looks promising as a method for improving near vision in hyperopes with presbyopia.

Patients should be offered a &34;menu" of options regarding what level of discussion takes place prior to cataract surgery.

Mixing and matching the ReZoom (AMO) and Tecnis (AMO) multifocal intraocular lenses (IOLs) produces enhanced visual outcomes and patient satisfaction.